Cargando…
The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study
BACKGROUND: Triggering receptor expressed on myeloid cell 1 (Trem1) is an important regulator of cellular inflammatory responses. Neuroinflammation is a common thread across various neurological diseases. Soluble Trem1 (sTrem1) in plasma is associated with the development of central nervous system d...
Autores principales: | Shi, Xiaolei, Wei, Tao, Hu, Yachun, Wang, Meng, Tang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446564/ https://www.ncbi.nlm.nih.gov/pubmed/36068612 http://dx.doi.org/10.1186/s12974-022-02582-z |
Ejemplares similares
-
CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study
por: Dong, Ming-Hao, et al.
Publicado: (2022) -
Identifying Suitable Targets for Alzheimer’s Disease and Other Eight Common Neurological Disorders Using the Human Plasma Proteome: A Mendelian Randomization Study
por: Wei, Tao, et al.
Publicado: (2023) -
Soluble TREM2: Innocent bystander or active player in neurological diseases?
por: Filipello, Fabia, et al.
Publicado: (2022) -
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
por: Ashton, Nicholas J., et al.
Publicado: (2019) -
Role of TREM-1 in pulmonary tuberculosis patients- analysis of serum soluble TREM-1 levels
por: Feng, Jia-Yih, et al.
Publicado: (2018)